CFM
MEDP icon

Catalyst Funds Management’s Medpace MEDP Stock Holding History

Catalyst Funds Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,040
Closed -$499K – 794
2026
Q1 		$499K Buy
+1,040
New +$533K 0.08% 249
2025
Q4 		– Sell
-600
Closed -$308K – 480
2025
Q3 		$308K Buy
+600
New +$262K 0.05% 324
2024
Q4 		– Sell
-200
Closed -$66.8K – 880
2024
Q3 		$66.8K Buy
+200
New +$76K 0.01% 657

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Catalyst Funds Management's MEDP Position: Q2 2026 in Review

Catalyst Funds Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 1,040 shares — an estimated $499K sold.

Catalyst Funds Management first reported a position in MEDP in Q3 2024 and held it in 3 quarters. The position peaked at $499K in Q1 2026. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Catalyst Funds Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 1,040 Medpace shares in Q2 2026, an estimated $499K.
  • Catalyst Funds Management first reported a position in Medpace in Q3 2024 and held it in 3 quarters.
  • Catalyst Funds Management's Medpace position peaked at $499K in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.